Release Date: 08.30.2016 | Location: All Metro Atlanta | Organization: Women in Technology - Technology Thought Leader Spotlight
Women in Technology (WIT) Thought Leader - Darnisha Grant Harrison
This Week's Women in Technology Thought Leader:
Darnisha Grant Harrison
Despite the odds being stacked against them, women founders are currently excelling in the technology sector. With 50% less access to funding and with only 7% of venture capitalist money supporting their products, women who are financed typically perform 63% better than their male counterparts.
Darnisha Grant Harrison is one of the first African American women in the world to be the Founder, President & CEO of a biopharmaceutical company. In this role she’s responsible for guiding the strategic direction and growth of Ennaid Therapeutics, based in Alpharetta, GA.
Once a Microbiologist and Chemist, Darnisha is a nationally recognized science entrepreneur with 22-plus years of experience in the Life Sciences. Prior to founding Ennaid Therapeutics in 2012, she spent 3-years as a scientist at Amgen and the University of Georgia, and 16-years in Business Development/Licensing as a Director for various pharmaceutical companies, notably: Penwest/JRS Pharma; Metrics, Inc; Banner Pharmacaps and Norwich Pharmaceuticals.
"My commitment to STEM runs deeply because the most exhilarating feeling in the world to me is to find early-stage, innovative science and develop it into therapeutic cures that can be beneficial to the well-being of humans and animals---safely and fast (bench to bedside safely and fast). My commitment to Women in Technology runs just as deeply because I want people of every gender to remain inspired by my journey and truly understand that making a global impact in Science-STEM has infinite possibilities."
- Darnisha Grant Harrison
Ennaid Therapeutics is a biopharma company developing cures (not vaccines) to help 400 million people worldwide who contract seemingly incurable diseases, like dengue virus, a life-debilitating, possibly deadly, mosquito-borne virus. Filling a gap not suited for big pharma, the company acquires early-stage, proprietary, innovative science and creates a fast-track development plan to be 1st-to-market with profitable therapeutic cures.
Ennaid is currently focused on developing antiviral drugs to treat Zika virus, dengue virus and other mosquito-borne illnesses using proprietary peptide inhibitors that block the entry of Zika virus and dengue virus into host cells. The company’s peptide inhibitors show >95% inhibition against Zika virus and >99% inhibition against dengue virus. Ennaid’s antiviral drugs may meet fast-track guidelines to accelerate new drug approval.
An expert negotiator and deal-maker Darnisha has identified, negotiated and closed drug development deals and strategic collaborations her entire career, and is expertly skilled in technology acquisition, licensing, strategic business development, business planning and brisk, successful execution of such plans. A member of the American Association for the Advancement of Science and the New York Academy of Sciences, she received her B.S. in Microbiology and Minor in Chemistry from LSU.
With Darnisha’s leadership, Ennaid Therapeutics is leading the challenge of developing and bringing innovative cures and leading edge healthcare technologies to formerly incurable disease, and is dedicated to saving lives and improving the health of millions of patients worldwide.
More About Darnisha Grant Harrison
LinkedIn: Darnisha Grant Harrison
Reading: I have just begun reading "True North: Discover Your Authentic Leadership" by Bill George. I just concluded a re-read of "The Big Leap" by Gay Hendricks.
Best Advice You’ve Ever Received: Allow ONLY your own B.S. to lead you---B.S. is Belief System, never someone else's while having fun along the way (if you aren't having fun, step back and reassess your Belief System).
About Women in Technology (WIT)
Women in Technology (WIT) passionately supports women at every stage of their STEM careers—from the classroom to the boardroom. We do this by telling the stories of successful women and by helping more women write their own. This takes place in a wide variety of formats—from educating middle and high school girls about the opportunities in science, technology, engineering, and math (STEM), to providing networking and education for professionals currently working in the field. With over 2,500 professionals attending our programs and events, over 500 students, and over 250 volunteers, WIT has become the largest, most active organization of its kind in the region.
Contact Name: WIT Thought Leaders
Company: Women in Technology